Zobrazeno 1 - 10
of 77
pro vyhledávání: '"MUNIRA, MOMIN"'
Autor:
AFREEN, SHAIKH DARAKHSHAN1 darakhshan201992@gmail.com, MUNIRA, MOMIN2
Publikováno v:
Indian Journal of Pharmaceutical Sciences. Jan/Feb2024, Vol. 86 Issue 1, p211-221. 11p.
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 58 (2023)
Alzheimer’s disease, a progressive neurodegenerative condition, is characterized by a gradual decline in cognitive functions. Current treatment approaches primarily involve the administration of medications through oral, parenteral, and transdermal
Externí odkaz:
https://doaj.org/article/d6a56dd913b644fca8515de470e0f4b0
Publikováno v:
In Biomedicine & Pharmacotherapy September 2021 141
Autor:
Kristin J. Adolfsen, Isolde Callihan, Catherine E. Monahan, Per Jr. Greisen, James Spoonamore, Munira Momin, Lauren E. Fitch, Mary Joan Castillo, Lindong Weng, Lauren Renaud, Carl J. Weile, Jay H. Konieczka, Teodelinda Mirabella, Andres Abin-Fuentes, Adam G. Lawrence, Vincent M. Isabella
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
PKU patients have elevated phenylalanine levels which can result in neurological impairment. Here the authors utilize biosensor-based ultra-high-throughput screening to optimize PAL activity in a synthetic biotic platform for improved in vivo perform
Externí odkaz:
https://doaj.org/article/026a2581af754d8aa8526f2be41ac1f4
Autor:
Daniel S. Leventhal, Anna Sokolovska, Ning Li, Christopher Plescia, Starsha A. Kolodziej, Carey W. Gallant, Rudy Christmas, Jian-Rong Gao, Michael J. James, Andres Abin-Fuentes, Munira Momin, Christopher Bergeron, Adam Fisher, Paul F. Miller, Kip A. West, Jose M. Lora
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Synthetic biology can be used to create rationally designed living therapeutics. Here the authors engineer E. coli Nissle to target STING activation in antigen presenting cells for the treatment of solid tumors and demonstrate preclinical activity in
Externí odkaz:
https://doaj.org/article/c274837c940442a5b5b9051d086275aa
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 22:950-972
Abstract: Attention Deficit Hyperactivity Disorder is a neurodevelopmental disorder, which is characterised by a distinct clinical pattern of inattention, hyperactivity as well as impulsivity, which in turn interferes with the day-to-day activities o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce4c938e92d5e246bc03b062fde706c
https://doi.org/10.2174/1871527321666220720103923
https://doi.org/10.2174/1871527321666220720103923
Publikováno v:
Recent Advances in Drug Delivery and Formulation. 17:61-70
Background: This study aims to formulate and characterize sorafenib-loaded resealed erythrocytes (SoRE) and investigate their anticancer activity in a rat model of hepatocellular carcinoma. Methods: SoRE were prepared by hypotonic dialysis of red blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e0b338d2bf9b715becf4288be5a8593
https://doi.org/10.2174/2667387817666230228145946
https://doi.org/10.2174/2667387817666230228145946
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2020)
Treatment of a variety of bowel diseases like Crohn’s disease, ulcerative colitis, colonic cancers, colonic pathologies, and systemic delivery of drugs at the target sites can be done with the help of targeted drug delivery technique. Conventional
Externí odkaz:
https://doaj.org/article/d41ee6c73f2b4f269b1574de390db0a3
Publikováno v:
Antibiotics, Vol 11, Iss 1, p 108 (2022)
Microbial pathogens are the most prevalent cause of chronic infections and fatalities around the world. Antimicrobial agents including antibiotics have been frequently utilized in the treatment of infections due to their exceptional outcomes. However
Externí odkaz:
https://doaj.org/article/1aa3963299424a9aa2968214e2227756
Publikováno v:
Pharmaceuticals, Vol 14, Iss 11, p 1201 (2021)
One of the major impediments to drug development is low aqueous solubility and thus poor bioavailability, which leads to insufficient clinical utility. Around 70–80% of drugs in the discovery pipeline are suffering from poor aqueous solubility and
Externí odkaz:
https://doaj.org/article/98e60f4a32404704a1139f759fb73c70